Logo image of EXPI

EXP WORLD HOLDINGS INC (EXPI) Stock Fundamental Analysis

NASDAQ:EXPI - Nasdaq - US30212W1009 - Common Stock - Currency: USD

10.12  -0.35 (-3.34%)

After market: 10.12 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to EXPI. EXPI was compared to 64 industry peers in the Real Estate Management & Development industry. EXPI has a great financial health rating, but its profitability evaluates not so good. EXPI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

EXPI had negative earnings in the past year.
EXPI had a positive operating cash flow in the past year.
In multiple years EXPI reported negative net income over the last 5 years.
Each year in the past 5 years EXPI had a positive operating cash flow.
EXPI Yearly Net Income VS EBIT VS OCF VS FCFEXPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

EXPI has a Return On Assets (-3.90%) which is comparable to the rest of the industry.
The Return On Equity of EXPI (-8.03%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 4.70%, EXPI is in the better half of the industry, outperforming 73.85% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for EXPI is below the industry average of 5.47%.
The last Return On Invested Capital (4.70%) for EXPI is above the 3 year average (3.18%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -3.9%
ROE -8.03%
ROIC 4.7%
ROA(3y)-1.22%
ROA(5y)5.76%
ROE(3y)-2.57%
ROE(5y)10.16%
ROIC(3y)3.18%
ROIC(5y)7.72%
EXPI Yearly ROA, ROE, ROICEXPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

EXPI's Operating Margin of 0.28% is in line compared to the rest of the industry. EXPI outperforms 58.46% of its industry peers.
EXPI's Operating Margin has declined in the last couple of years.
EXPI has a Gross Margin of 7.43%. This is in the lower half of the industry: EXPI underperforms 76.92% of its industry peers.
EXPI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.28%
PM (TTM) N/A
GM 7.43%
OM growth 3Y-21.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.52%
GM growth 5Y-2.67%
EXPI Yearly Profit, Operating, Gross MarginsEXPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXPI is destroying value.
The number of shares outstanding for EXPI has been reduced compared to 1 year ago.
EXPI has more shares outstanding than it did 5 years ago.
EXPI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EXPI Yearly Shares OutstandingEXPI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EXPI Yearly Total Debt VS Total AssetsEXPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

EXPI has an Altman-Z score of 14.76. This indicates that EXPI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 14.76, EXPI belongs to the top of the industry, outperforming 93.85% of the companies in the same industry.
EXPI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.76
ROIC/WACC0.52
WACC9.07%
EXPI Yearly LT Debt VS Equity VS FCFEXPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

EXPI has a Current Ratio of 1.34. This is a normal value and indicates that EXPI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.34, EXPI perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
A Quick Ratio of 1.34 indicates that EXPI should not have too much problems paying its short term obligations.
The Quick ratio of EXPI (1.34) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
EXPI Yearly Current Assets VS Current LiabilitesEXPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

EXPI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.11%, which is quite good.
EXPI shows a small growth in Revenue. In the last year, the Revenue has grown by 4.71%.
Measured over the past years, EXPI shows a very strong growth in Revenue. The Revenue has been growing by 36.05% on average per year.
EPS 1Y (TTM)11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250%
Revenue 1Y (TTM)4.71%
Revenue growth 3Y6.6%
Revenue growth 5Y36.05%
Sales Q2Q%1.26%

3.2 Future

The Earnings Per Share is expected to grow by 143.10% on average over the next years. This is a very strong growth
Based on estimates for the next years, EXPI will show a small growth in Revenue. The Revenue will grow by 3.16% on average per year.
EPS Next Y185%
EPS Next 2Y143.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.33%
Revenue Next 2Y3.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EXPI Yearly Revenue VS EstimatesEXPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
EXPI Yearly EPS VS EstimatesEXPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

EXPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 86.27, the valuation of EXPI can be described as expensive.
Based on the Price/Forward Earnings ratio, EXPI is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
EXPI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 35.19.
Industry RankSector Rank
PE N/A
Fwd PE 86.27
EXPI Price Earnings VS Forward Price EarningsEXPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

EXPI's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXPI indicates a rather cheap valuation: EXPI is cheaper than 89.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.78
EV/EBITDA 70.42
EXPI Per share dataEXPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXPI's earnings are expected to grow with 143.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y143.1%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

EXPI has a Yearly Dividend Yield of 1.91%.
EXPI's Dividend Yield is rather good when compared to the industry average which is at 3.44. EXPI pays more dividend than 90.77% of the companies in the same industry.
EXPI's Dividend Yield is comparable with the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 1.91%

5.2 History

EXPI has been paying a dividend for over 5 years, so it has already some track record.
EXPI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
EXPI Yearly Dividends per shareEXPI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

The earnings of EXPI are negative and hence is the payout ratio. EXPI will probably not be able to sustain this dividend level.
DP-176.32%
EPS Next 2Y143.1%
EPS Next 3YN/A
EXPI Yearly Income VS Free CF VS DividendEXPI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

More info and screens

EXP WORLD HOLDINGS INC

NASDAQ:EXPI (7/11/2025, 8:08:27 PM)

After market: 10.12 0 (0%)

10.12

-0.35 (-3.34%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners40.63%
Inst Owner Change0%
Ins Owners43.17%
Ins Owner Change-0.5%
Market Cap1.58B
Analysts80
Price Target10.97 (8.4%)
Short Float %19.76%
Short Ratio13.46
Dividend
Industry RankSector Rank
Dividend Yield 1.91%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP-176.32%
Div Incr Years3
Div Non Decr Years3
Ex-Date05-19 2025-05-19 (0.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-440.4%
Min EPS beat(2)-928.9%
Max EPS beat(2)48.1%
EPS beat(4)1
Avg EPS beat(4)-275.84%
Min EPS beat(4)-928.9%
Max EPS beat(4)48.1%
EPS beat(8)2
Avg EPS beat(8)-166.91%
EPS beat(12)3
Avg EPS beat(12)-118.9%
EPS beat(16)7
Avg EPS beat(16)-38.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-5.92%
Max Revenue beat(2)4.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.25%
Min Revenue beat(4)-5.92%
Max Revenue beat(4)4.39%
Revenue beat(8)5
Avg Revenue beat(8)-0.2%
Revenue beat(12)5
Avg Revenue beat(12)-2.14%
Revenue beat(16)9
Avg Revenue beat(16)1.58%
PT rev (1m)0%
PT rev (3m)-27.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.24%
EPS NY rev (1m)-79.17%
EPS NY rev (3m)-85.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 86.27
P/S 0.35
P/FCF 9.78
P/OCF 9.24
P/B 7.45
P/tB 8.37
EV/EBITDA 70.42
EPS(TTM)-0.08
EYN/A
EPS(NY)0.12
Fwd EY1.16%
FCF(TTM)1.03
FCFY10.22%
OCF(TTM)1.09
OCFY10.82%
SpS29.32
BVpS1.36
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.9%
ROE -8.03%
ROCE 5.94%
ROIC 4.7%
ROICexc 4.7%
ROICexgc 5.27%
OM 0.28%
PM (TTM) N/A
GM 7.43%
FCFM 3.53%
ROA(3y)-1.22%
ROA(5y)5.76%
ROE(3y)-2.57%
ROE(5y)10.16%
ROIC(3y)3.18%
ROIC(5y)7.72%
ROICexc(3y)6.95%
ROICexc(5y)19.72%
ROICexgc(3y)9.37%
ROICexgc(5y)31.83%
ROCE(3y)4.03%
ROCE(5y)9.78%
ROICexcg growth 3Y-5.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y-8.74%
ROICexc growth 5YN/A
OM growth 3Y-21.55%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.52%
GM growth 5Y-2.67%
F-Score6
Asset Turnover10.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 95.79%
Cap/Sales 0.21%
Interest Coverage 250
Cash Conversion 761.9%
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z 14.76
F-Score6
WACC9.07%
ROIC/WACC0.52
Cap/Depr(3y)91.01%
Cap/Depr(5y)129.14%
Cap/Sales(3y)0.21%
Cap/Sales(5y)0.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250%
EPS Next Y185%
EPS Next 2Y143.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.71%
Revenue growth 3Y6.6%
Revenue growth 5Y36.05%
Sales Q2Q%1.26%
Revenue Next Year2.33%
Revenue Next 2Y3.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y267%
EBIT growth 3Y-16.38%
EBIT growth 5YN/A
EBIT Next Year404.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.44%
FCF growth 3Y-7.61%
FCF growth 5Y29.74%
OCF growth 1Y10.25%
OCF growth 3Y-8.04%
OCF growth 5Y28.31%